In the past shared mutations (particularly of TP53) or patterns of loss of heterozygosity (LOH) have been the main biomarkers used to infer the presence or absence of a clonal relationship between separate biopsies from a single individual in lung cancer and pre-invasive bronchial dysplasia 5–9. This evidence concerns the gene TP53 and lung cancer.